Clinical Trial Update: Personalized Antiplatelet Secondary Stroke PRevenTion [Phase 2]

View source ↗

Summary

Phase 2 trial update on personalized antiplatelet therapy for secondary prevention after ischemic stroke or transient ischemic attack.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Ischemic Stroke, TIA | Phase 2 | Status: COMPLETED